Research Search Results

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Status: Active, Recruiting

The purpose of this study is to find out how genetics, biologics and behavior might contribute to

Status: Active, Recruiting

ACE-536 VS.Epoetin Alfa for the TX of Anemia Due to IPSS-R Very Low,Low or Intermediate Risk MDS in ESA Naïve Subjects Who Require RBC Transfusions

Status: Active, Recruiting

Connect® MDS/AML Disease Registry

Status: Active, Recruiting

Randomized, open-label study of TTFields, 150kHz concomitant with gemcitabine and nab-paclitaxel for treatment of locally-advanced pancreatic adenocarcinoma

Status: Active, Recruiting

A Randomized, Double-Blind, Placebo-Controlled Study of the PI3Kd Inhibitor Parsaclisib Plus Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3Kd Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibros

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Status: Active, Recruiting

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma

Status: Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma

Status: Active, Recruiting